Point of Care Testing (POCT) Market By Product Types (Devices and Accessories/ Consumables, Others) By Therapeutics Applications (Blood Glucose Monitoring, Infectious Diseases, Others) Regional Analysis and Forecast - 2026
- OI-66 |
- Published date: Jan, 2019 |
- In Vitro Diagnostics |
- Pages
The global Point of Care (PoC) diagnostics market size was estimated at USD 19.7 billion in 2017. The ability of POC diagnostic tests to render immediate results thus providing improved patient care coupled with rising market penetration of PACS (picture archiving and communication systems) and EMR (electronic medical records) have accelerated the remarkable success of POC devices.
The POCT market includes product types, such as devices/ instruments, accessories/ consumables and software & other solutions. The market consists of various types of devices for different therapeutics application, such as blood glucose monitoring, infectious diseases, blood gas & electrolytes, anticoagulant management, pregnancy & fertility, substance abuse, urinalysis, cardiac markers, lipids, HbA1C, tumor/cancer markers and several others.
The global POCT market is estimated to grow over $23.92 billion by 2026. The rise in the geriatric population along with the increased prevalence of chronic diseases is expected to boost the demand for POCT devices and drive growth of the global market. The POCT devices are portable, have quick Turn Around Time (TAT) and are easy to use which makes them more attractive for the end users, thereby increasing their demand and usage.
The global Point of Care (PoC) diagnostics market size was estimated at USD 19.7 billion in 2017. The ability of POC diagnostic tests to render immediate results thus providing improved patient care coupled with rising market penetration of PACS (picture archiving and communication systems) and EMR (electronic medical records) have accelerated the remarkable success of POC devices.
The POCT market includes product types, such as devices/ instruments, accessories/ consumables and software & other solutions. The market consists of various types of devices for different therapeutics application, such as blood glucose monitoring, infectious diseases, blood gas & electrolytes, anticoagulant management, pregnancy & fertility, substance abuse, urinalysis, cardiac markers, lipids, HbA1C, tumor/cancer markers and several others.
The global POCT market is estimated to grow over $23.92 billion by 2026. The rise in the geriatric population along with the increased prevalence of chronic diseases is expected to boost the demand for POCT devices and drive growth of the global market. The POCT devices are portable, have quick Turn Around Time (TAT) and are easy to use which makes them more attractive for the end users, thereby increasing their demand and usage.
-
Data Collation (Primary & Secondary)
-
In-house Estimation (Based on proprietary databases and Models)
-
Market Triangulation
-
Forecasting
-
Market-related information is assembled from both primary and secondary sources.
-
Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
-
Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others.
-
Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.
